Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2006
06/21/2006CN1260345C Method for producing a microorganism and amide compound
06/21/2006CN1260251C Transcription factor for regulating and controlling gibberellin generation, coded gene and application thereof
06/20/2006USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins
06/20/2006US7064249 Plants transformed to express Cry2A δ-endotoxins
06/20/2006US7064248 Method of preparing fertile transgenic corn plants by microprojectile bombardment
06/20/2006US7064247 expression cassettes; transgenic cells/seeds/plants
06/20/2006US7064246 Controlling gene expression inhibition; obtain cells, incubate with preferential nucleotide sequences and transposase, monitor adjustment in gene expression
06/20/2006US7064245 Process for reconstructing a non-human mammalian embryo by nuclear transfer using a heat treated donor nucleus and preparaing a non-human mammal
06/20/2006US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
06/20/2006US7064243 Transgenic roundworm for monitoring inhibitors of protein secretion pathways; parasiticides; disease resistant plants
06/20/2006US7064196 Genes encoding carotenoid compounds
06/20/2006US7064195 Fusion proteins of mycobacterium tuberculosis antigens and their uses
06/20/2006US7064194 Vectors for animal cells and utilization thereof
06/20/2006US7064193 Therapeutic molecules
06/20/2006US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders
06/20/2006US7064185 Antibody for human Cyr61
06/20/2006US7064184 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens
06/20/2006US7064183 Use in impacting plant microbial pathogens and in enhancing plant disease resistance to microbial pathogens
06/20/2006US7064182 A polypeptide with serine protease inhibition activity
06/20/2006US7064181 A nonapeptide containing an amino acid sequence: ala, pro, ala, his, arg, gly, arg, gly, gly, amide, ester or salt; ability to bind to a receptor protein of specific sequence
06/20/2006US7064111 activating or enhancing T-cell response by locally administering a herpes simplex virus vector with an expressible nucleotide sequence for the soluble costimulatory factor B7-1-Ig or B7-2-Ig, so that the factor is expressed by tumor cells or cells in the immediate area of the tumor
06/20/2006US7064107 Prevention and reduction of blood loss
06/20/2006US7064106 Protein, as a reagent for screening a compound that inhibit the binding of the protein to insulin responsive aminopeptidase or to glucose transporter 4; useful as a preventive/remedy for hyperglycemia and diabetes melliuts etc.
06/20/2006US7063973 HDAC9 polypeptides and polynucleotides and uses thereof
06/20/2006US7063972 Cytochrome P450 monooxygenase CYP52A2A from Candida tropicalis
06/20/2006US7063971 Phosphodiesterase enzymes
06/20/2006US7063966 Quantitative analysis; complexing with antibodies
06/20/2006US7063965 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1.
06/20/2006US7063964 Nucleic acids encoding IL-12 antibody
06/20/2006US7063963 Nucleotide sequences consisiting of DNA viral open reading frames which code proteins which can be used to prepare genetic vaccines which prevent viral diseases
06/20/2006US7063962 DNA sequences for regulating transcription
06/20/2006US7063961 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells.
06/20/2006US7063960 Interacting the immature dendritic cels with an antigen ex vivo so that the surface antigen is presented; inducing maturation ex vivo; and contacting with a modulator comprising TRANCE or derivative
06/20/2006US7063958 that encode a receptor for leptin, including a naturally occurring soluble form of the receptor that is expected to modulate, especially agonize, leptin activity; could be used to treat obesity
06/20/2006US7063956 Culturing a recombinant cell containing farnesyl pyrophosphate and isopentyl pyrophosphate for expression of enzymes which catalyze the converion of farnesyl pyrophosphate and iopentyl pyrophosphate to zeaxanthin
06/20/2006US7063955 Genes have been isolated from Rhodococcus and Deinococcus which encode a specific lycopene beta -cyclase capable of converting acyclic carotenoids with atleast one psi-end group to corresponding asymetric caratenoid
06/20/2006US7063954 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
06/20/2006US7063953 Human voltage gated sodium channel β1A subunit and methods of use
06/20/2006US7063950 Nucleic acids encoding human calcium channel and methods of use thereof
06/20/2006US7063949 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes
06/20/2006US7063947 constructing a library of randomly combined transcription regulatory double stranded DNA sequence elements, recognized by transcription regulators; inseerting the elements upstream of a minimum promoter followed by a reporter gene in a vector; and screening for enhanced expression of the reporter gene
06/20/2006US7063946 Methods, reagents, kits and apparatus for protein function analysis
06/20/2006US7063945 To be used in hybridization methods, for the determination of a nucleic acid
06/20/2006US7063943 Methods for producing members of specific binding pairs
06/20/2006US7063853 DNA immunization against Chlamydia infection
06/20/2006US7063851 Herpes viruses for immune modulation
06/20/2006US7063845 Human anti-CD40 antibodies
06/20/2006US7063843 Cloning and regulation of an endothelial cell protein C/activated protein C receptor
06/20/2006US7063841 Mammalian cell surface antigens; related reagents
06/20/2006US7063835 Virus strains
06/20/2006US7063829 Wasp family protein fragments, and use thereof
06/20/2006CA2127700C Marek's disease virus recombinant poxvirus vaccine
06/20/2006CA2049472C Monoclonal antibodies to leptosphaeria
06/17/2006CA2585798A1 Process for the control of production of fine chemicals
06/15/2006WO2006063356A1 Regulation of epigenetic control of gene expression
06/15/2006WO2006063301A1 Genetically modified tumor cells as cancer vaccines
06/15/2006WO2006063247A2 Regulated expression of transgenes in the central nervous system of mammals
06/15/2006WO2006063182A2 Orthopic reconstituted human breast tumor model in mouse
06/15/2006WO2006063121A2 Method and system for gps augmentation of mail carrier efficiency
06/15/2006WO2006062971A2 Modulating plant carbon levels
06/15/2006WO2006062723A2 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
06/15/2006WO2006062596A2 RNAi MODULATION OF RSV, PIV AND OTHER RESPIRATORY VIRUSES AND USES THEREOF
06/15/2006WO2006062507A1 Methods of prescreening cells for nuclear transfer procedures
06/15/2006WO2006062398A2 Methods for the production and secretion of modified peptides
06/15/2006WO2006062369A1 Method of inhibiting expression of target mrna using sirna consisting of nucleotide sequence complementary to said target mrna
06/15/2006WO2006062266A1 Genes of a korean isolate rbiv and a vaccine against rbiv
06/15/2006WO2006062259A1 Method for production of plant cell having chromosome loss
06/15/2006WO2006062200A1 Nucleic acid library and protein library
06/15/2006WO2006062189A1 Transformant expressing nitrile hydratase
06/15/2006WO2006062173A1 Bcl-xL HETERODIMER INHIBITORY PEPTIDE ENHANCING THE EFFECT OF ANTICANCER AGENT AND METHOD OF SCREENING THE SAME
06/15/2006WO2006062169A1 System for screening protein or peptide localized in specific area in cell
06/15/2006WO2006062135A1 Diagnostic for mental disease
06/15/2006WO2006062134A1 Ip3 receptor-deficient mouse
06/15/2006WO2006062130A1 Microorganism having improved gene participating in hydrogen production ability and method of producing hydrogen by using the microorganism
06/15/2006WO2006062118A1 Novel markers for predicting prognosis of papillary carcinoma of the thyroid
06/15/2006WO2006062094A1 Novel cancer antigen peptide and the use thereof
06/15/2006WO2006062009A1 Dna chain elongation method, dna chain amplification method and microarray for dna chain elongation
06/15/2006WO2006061994A1 Method of examining gene sequence
06/15/2006WO2006061985A1 Luciferase emission method and emission reagent for multicolor simultaneous measurement
06/15/2006WO2006061945A1 Method for quantitative determination of propionic acid
06/15/2006WO2006061906A1 Novel luciferase-encoding gene
06/15/2006WO2006061650A2 Methods, products and uses involving platelets and/or the vasculature
06/15/2006WO2006061643A1 Method for vaccinating usign a prime-boost regime and hsv as a vector
06/15/2006WO2006061521A2 Polynucleotide sequences with promoter activity specific of plant roots
06/15/2006WO2006061425A2 Production of beta-lactam antibiotics by genetically modified non-naturally producing microorganisms
06/15/2006WO2006061418A2 Methods and agents useful in treating conditions characterized by mucus hyperproduction/hypersecretion
06/15/2006WO2006061406A2 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same
06/15/2006WO2006061396A1 Compounds analogous to lipid membranes in archaebacteria and liposomal compositions including said compounds
06/15/2006WO2006061242A2 Use of pta peptides for stratification of individuals having cancer
06/15/2006WO2006061174A2 Rhamnose promoter expression system
06/15/2006WO2006061137A1 Gdh mutant having improved chemical stability
06/15/2006WO2006060914A1 Plant proteins having an abscisic acid binding site and methods of use
06/15/2006WO2006060898A1 Method for treating inflammatory disorders
06/15/2006WO2006047367A3 Suppression of endogenous immunoglubolin expression in non-human transgenic animals
06/15/2006WO2006045591A3 Method and constructs for delivering double stranded rna to pest organisms
06/15/2006WO2006045590A3 Multidomain rna molecules comprising at least one aptamer for delivering double stranded rna to pest organisms
06/15/2006WO2006043972A8 Chimeric protein
06/15/2006WO2006039045A3 Adenoviral vectors able to transduce apcs, potential use in immune response generation
06/15/2006WO2006033672A3 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost
06/15/2006WO2006032278A9 Subtilases